Your Health, We Care

Home > Photo Wall > Honor and qualification

Production approval for RINVOQ

Release date: 2024-07-10 11:36:06     Recommended: 78

04L1091_24 乌帕替尼 批文_00.jpg

RINVOQ is a drug used to treat diseases such as arthritis, atopic dermatitis, ulcerative colitis, Crohn's disease, ankylosing spondylitis, and non radiographic axial spinal arthritis. It is an oral selective Janus kinase inhibitor mainly used for the treatment of immune-mediated diseases such as moderate to severe active ulcerative colitis, atopic dermatitis, and rheumatoid arthritis.

Company News

Research News

Drug news